Pharmacoepidemiology of Ceftazidime-Avibactam Use: A Retrospective Cohort Analysis of 210 US Hospitals

BACKGROUND: Ceftazidime-avibactam has in vitro activity against some carbapenem-resistant gram-negative infections (GNIs), and therefore may be a useful alternative to more toxic antibiotics such as colistin. Understanding ceftazidime-avibactam uptake and usage patterns would inform hospital formula...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Infect Dis
Hlavní autoři: Strich, Jeffrey R, Ricotta, Emily, Warner, Sarah, Lai, Yi Ling, Demirkale, Cumhur Y, Hohmann, Samuel F, Rhee, Chanu, Klompas, Michael, Palmore, Tara, Powers, John H, Dekker, John P, Adjemian, Jennifer, Matsouaka, Roland, Woods, Christopher W, Danner, Robert L, Kadri, Sameer S
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2020
Témata:
Major Articles and Commentaries
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7884805/
https://ncbi.nlm.nih.gov/pubmed/32107536
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciaa061
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky